Neil joined CellCentric in May 2025

Neil holds a BSc (Hons) in Pharmacology from the University of Edinburgh and earned his PhD from the University of Dundee in 2006. He has over eight years of Regulatory Affairs experience gained within oncology-focused start-ups and small biotech companies. Neil is a registered member of TOPRA and has served on the TOPRA in Scotland steering committee since 2017, acting as Chair since 2020.

In his previous roles, Neil has coordinated and led a wide range of successful regulatory submissions, including Clinical Trial Applications, INDs, Scientific Advice procedures, Fast Track and Orphan Drug Applications, and managed interactions with regulatory authorities and ethics committees. He has been responsible for regulatory aspects of multiple clinical trials across Phases 1–3 in the US, EU, Asia, and Australia, including submissions strategy, providing regulatory guidance to clinical project management teams and serving as the primary liaison for CRO regulatory personnel.

Additionally, Neil has led the development and implementation of QMS processes to streamline activities and ensure compliance with regulatory requirements.